Irwindeep Sandhu MD

Dr. Irwindeep Sandhu is a hematologist and oncologist who treats patients at the Cross Cancer Institute. He has a special interest in apheresis, leukemia, multiple myeloma plasma cell dyscrasias, and cellular therapy. In 2016, he received a Champion of Care Award from a nomination by patient groups.

After graduating from the University of Alberta’s medical school, Dr. Irwindeep Sandhu completed an internal medicine residency at the University of British Columbia and a hematology residency at McMaster University. He was recruited to the University of Alberta in 2009, where in addition to his position in the Division of Hematology, he has an adjunct appointment in the Department of Oncology.

Dr. Sandhu is the acting lead for the Northern Alberta Blood and Marrow Program and the medical director for the cellular apheresis program. He is a fellow in the Alberta Chapter of the American College of Physicians. He coordinates Hematologic care services for the Northwest Territories and serves as an inpatient teaching attending for the malignant hematology service at the Cross Cancer Institute.

Dr. Sandhu conducts translational research through collaborations with his colleagues and administers clinical trials in blood diseases such as acute leukemia and multiple myeloma. His findings have been published in several leading scientific journals including the New England Journal of Medicine, Haematologica, Blood, and Leukemia. His clinical and research contributions have helped develop the University of Alberta’s reputation as a leukemia center and the Cross Cancer Institute’s strengths in multiple myeloma and cellular therapy.